Corcept Therapeutics (CORT) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $122.25 +0.99%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.5 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
